Relationships Between Metabolic and Bariatric Surgery and Adverse Kidney Outcomes: An Analysis of a Retrospective Cohort
MBS was associated with markedly lower risks for adverse kidney outcomes in patients with obesity. These results support the potential for MBS as a weight loss intervention to preserve kidney function in patients with obesity, both with and without T2D.
Authors
- Yongming Qu (ORCID: https://orcid.org/0000-0003-3643-8066)
- Xiwei Chen (ORCID: https://orcid.org/0000-0003-1868-8387)
- Stephanie Dickinson (ORCID: https://orcid.org/0000-0002-2998-4467)
- Allon N. Friedman (ORCID: https://orcid.org/0000-0003-2515-1748)
- Vipin Arora (ORCID: https://orcid.org/0000-0003-3880-9000)
- Carol F Kirkpatrick
- Douglas Landsittel (ORCID: https://orcid.org/0000-0002-0452-304X)
- Sumayyah Ali
- Kevin Maki
- Bailey K. Ortyl (ORCID: https://orcid.org/0000-0001-7936-0698)
Institutions
- Idaho State University (US)
- Eli Lilly (United States) (US)
- Indiana University Bloomington (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
- University at Buffalo, State University of New York (US)
Publication Details
- Journal
- Obesity Science & Practice
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/osp4.70109
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company